PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Internal Medicine10.3904/kjim.2014.29.6.8302014296830Transformation into large-cell neuroendocrine carcinoma associated with acquired resistance to erlotinib in nonsmall cell lung cancerJeong Uk Lim, In Sook Woo, Yun Hwa Jung, Jae Ho Byeon, Chan Kwon Park, Tae Jung Kim, Hyo Rim Kimhttp://synapse.koreamed.org/pdf/10.3904/kjim.2014.29.6.830, http://synapse.koreamed.org/DOIx.php?id=10.3904/kjim.2014.29.6.830, http://www.kjim.org/upload/kjim-29-6-20_830-833.pdf
Reactions Weekly10.1007/s40278-017-36619-7201716711185-185Erlotinib/gefitinibhttp://link.springer.com/article/10.1007/s40278-017-36619-7/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-017-36619-7.pdf, http://link.springer.com/content/pdf/10.1007/s40278-017-36619-7.pdf
Lung Cancer10.1016/0169-5002(95)98854-41995123292Myasthenic (Eaton-Lambert) syndrome associated with pulmonary large-cell neuroendocrine carcinomahttps://api.elsevier.com/content/article/PII:0169500295988544?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500295988544?httpAccept=text/plain
Reactions Weekly10.1007/s40278-019-60759-x201917491294-294Osimertinibhttp://link.springer.com/content/pdf/10.1007/s40278-019-60759-x.pdf, http://link.springer.com/article/10.1007/s40278-019-60759-x/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-019-60759-x.pdf
Reactions Weekly10.1007/s40278-015-10528-5201515771115-115Erlotinibhttp://link.springer.com/content/pdf/10.1007/s40278-015-10528-5.pdf, http://link.springer.com/article/10.1007/s40278-015-10528-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-10528-5
Reactions Weekly10.1007/s40278-020-73660-y20201787122-22Afatinib/erlotinibhttp://link.springer.com/content/pdf/10.1007/s40278-020-73660-y.pdf, http://link.springer.com/article/10.1007/s40278-020-73660-y/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-020-73660-y.pdf
Lung Cancer10.1016/j.lungcan.2004.06.0182005472225-233Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinomaWei-Xia Peng, Takaaki Sano, Tetsunari Oyama, Osamu Kawashima, Takashi Nakajimahttps://api.elsevier.com/content/article/PII:S0169500204003046?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500204003046?httpAccept=text/plain
Lung Cancer10.1016/j.lungcan.2015.09.0022015902364-368Transformation to large cell neuroendocrine carcinoma as acquired resistance mechanism of EGFR tyrosine kinase inhibitorMariko Kogo, Ryoko Shimizu, Keiichiro Uehara, Yutaka Takahashi, Masaki Kokubo, Yukihiro Imai, Keisuke Tomiihttps://api.elsevier.com/content/article/PII:S0169500215300477?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0169500215300477?httpAccept=text/xml
Reactions Weekly10.1007/s40278-015-10041-0201515751100-100Erlotinibhttp://link.springer.com/content/pdf/10.1007/s40278-015-10041-0.pdf, http://link.springer.com/article/10.1007/s40278-015-10041-0/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-10041-0
Lung Cancer10.1016/s0169-5002(05)81151-1200549S291P-658 Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinomaK. Hiroshima, A. Iyoda, T. Shida, K. Shibuya, T. Iizasa, T. Fujisawa, Y. Nakatanihttps://api.elsevier.com/content/article/PII:S0169500205811511?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500205811511?httpAccept=text/plain